Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The cost of myopic pandemic response

Sarah Nowak, Pedro Nascimento de Lima, Raffaele Vardavas
doi: https://doi.org/10.1101/2024.02.19.24303020
Sarah Nowak
aUniversity of Vermont, Burlington, VT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sarah.nowak{at}med.uvm.edu
Pedro Nascimento de Lima
bRAND, Arlington, VA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raffaele Vardavas
cRAND, Santa Monica, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Prior to the availability of COVID-19 vaccines, non-pharmaceutical interventions (NPIs) served as a primary strategy to mitigate the spread of the disease. However, the efficiency of these interventions relies on understanding and incorporating human behavior into infectious disease models. This study addresses the need for models that better account for the influence of temporal discounting on behavioral dynamics to enhance forecasting accuracy and develop robust mitigation strategies. Our previous research introduced Known Time Horizon (KTH) policies, optimizing social distancing measures based on a central planner’s rational assessment of the pandemic’s time frame and associated costs. In this paper, we contrast the KTH policy with a model reflecting myopic decision-making, an extreme form of temporal discounting that emphasizes short-term outcomes over long-term consequences. By comparing the expected social distancing behavior under myopic decision-making with the optimal policy derived from KTH approaches, we elucidate the impact of temporal bias on social distancing practices and assess its implications for infection dynamics and associated costs. We find that myopic policy always results in greater total costs throughout an epidemic compared to a KTH policy. However, each cost component – the costs of infection and social distancing – derived from a myopic strategy may be either larger or smaller than the component costs for a strategy developed using a full optimization model, depending on the specific parameters involved as myopic decision-makers seek to delay both costs of social distancing and infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We wish to thank the National Cancer Institute (R21CA157571), and the National Institute of Allergies and Infectious Diseases (R01AI118705 & R01AI160240) for providing support in projects that led to preliminary work and ideas that motivated this project. Dr. Nowak acknowledges support from the Blodwen S. Huber Early Career Green and Gold Professor in Pathology and Laboratory Medicine at The Robert Larner, M.D. College of Medicine as well as support from The National Institute of General Medical Sciences 3P20GM125498-04S1 and 2P20GM125498P-06.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All code used is available at: https://github.com/pedroliman/covid19-bpv/tree/myopic

https://github.com/pedroliman/covid19-bpv/tree/myopic

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 20, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The cost of myopic pandemic response
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The cost of myopic pandemic response
Sarah Nowak, Pedro Nascimento de Lima, Raffaele Vardavas
medRxiv 2024.02.19.24303020; doi: https://doi.org/10.1101/2024.02.19.24303020
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The cost of myopic pandemic response
Sarah Nowak, Pedro Nascimento de Lima, Raffaele Vardavas
medRxiv 2024.02.19.24303020; doi: https://doi.org/10.1101/2024.02.19.24303020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)